EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Efficacy and Safety of Oral Administration of Wine Lees Extract (WLE)-Derived Ceramides and Glucosylceramides in Enhancing Skin Barrier Function: A Randomized, Double-Blind, Placebo-Controlled Study

Angga Sanjaya, Akiko Ishida, Xuan Li, Yugweng Kim, Hiroaki Yamada iD, Takashi Kometani, Yusuke Yamashita, Young-Il Kim

Nutrients · 2024

DOI: 10.3390/nu16132100 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Angga Sanjaya und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pharma Foods International Co., Ltd., Kyoto 615-8245, Japan. Hauptthemen laut MEDLINE: Ceramides, Plant Extracts, Skin, Glucosylceramides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Our search for plant-derived ceramides from sustainable sources led to the discovery of ceramides and glucosylceramides in wine lees.

Objective

This study evaluated the efficacy and safety of wine lees extract (WLE)-derived ceramides and glucosylceramides in enhancing skin barrier function.

Methods

A randomized, double-blind, placebo-controlled study was conducted with 30 healthy Japanese subjects aged 20–64. Subjects were allocated to receive either the WLE-derived ceramides and glucosylceramides (test group) or placebo for 12 weeks. The primary outcome was transepidermal water loss (TEWL), and secondary outcomes included skin hydration, visual analog scale (VAS) of itching sensation, and the Japanese Skindex-29.

Results

One participant withdrew for personal reasons, resulting in 29 subjects for data analysis (placebo n = 15; test n = 14). The test group showed a tendency of lower TEWL compared to the placebo after 8 weeks (p = 0.07). Furthermore, after 12 weeks of administration, the test group had significantly lower TEWL than the placebo (p = 0.04). On the other hand, no significant differences were observed in the secondary outcome parameters. No adverse events related to the supplements were reported.

Conclusions

Oral supplementation of WLE-derived ceramides and glucosylceramides is a prominent and safe approach to enhancing skin barrier function and health.

Trial registration

(UMIN000050422).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CeramidesPlant ExtractsSkinGlucosylceramidesHumansDouble-Blind MethodAdultMaleFemaleMiddle AgedAdministration, OralYoung AdultWineWater Loss, Insensible

Stichwörter der Autor:innen

ceramidesclinical studyglucosylceramidesskin barriertransepidermal water loss (TEWL)wine lees

Substanzen

CeramidesPlant ExtractsGlucosylceramides

Autor:innen und Institutionen

  • Pharma Foods International Co., Ltd., Kyoto 615-8245, Japan.

ORCID-Profile: Hiroaki Yamada

Zitieren

APA

Sanjaya, A., Ishida, A., Li, X., Kim, Y., Yamada, H., Kometani, T., Yamashita, Y., & Kim, Y. I. (2024). Efficacy and Safety of Oral Administration of Wine Lees Extract (WLE)-Derived Ceramides and Glucosylceramides in Enhancing Skin Barrier Function: A Randomized, Double-Blind, Placebo-Controlled Study. Nutrients. https://doi.org/10.3390/nu16132100

Vancouver

Sanjaya A, Ishida A, Li X, Kim Y, Yamada H, Kometani T, et al. Efficacy and Safety of Oral Administration of Wine Lees Extract (WLE)-Derived Ceramides and Glucosylceramides in Enhancing Skin Barrier Function: A Randomized, Double-Blind, Placebo-Controlled Study. Nutrients. 2024. doi:10.3390/nu16132100

BibTeX
@article{Sanjaya2024,
  author = {Sanjaya, Angga and Ishida, Akiko and Li, Xuan and Kim, Yugweng and Yamada, Hiroaki and Kometani, Takashi and Yamashita, Yusuke and Kim, Young-Il},
  title = {Efficacy and Safety of Oral Administration of Wine Lees Extract (WLE)-Derived Ceramides and Glucosylceramides in Enhancing Skin Barrier Function: A Randomized, Double-Blind, Placebo-Controlled Study},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16132100}
}
Kostenlos starten →